Alcohol has been shown to be a modifiable risk factor in a number of ocular diseases, and recent research suggests glaucoma may be one of them. Those with or at risk for glaucoma may benefit from reducing their alcohol consumption.
Sunday, May 08, 2022
Wednesday, March 17, 2021
Friday, March 05, 2021
Allergan announced that it has submitted a new drug application to the FDA for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on the NDA by the end of 2021.
Tuesday, March 02, 2021
Upon examining the effects of exposure to high-dose sex steroid hormones, researchers recently observed improvement in tear function test results following the use of estradiol. They noted that the use of estradiol during menopause could improve dry eye symptoms in patients.
Corneal nerves are sometimes cut when the flap is made during LASIK. Fortunately, treatment with a nerve growth factor (NGF) has demonstrated the ability to both stimulate corneal nerve regeneration and potentially treat dry eye, a common postoperative complication of LASIK. Researchers recently studied its effects and found that NGF had “an obvious effect” on nerve repair and a potential for improvement of dry eye symptoms.
Monday, February 22, 2021
Reported in Review of Optometry:
People who partake in low-to-moderate alcohol consumption, specifically red wine, may be at a lower risk of needing cataract surgery, a new study suggests.
Thursday, June 18, 2020
"high doses of oral riboflavin combined with sunlight can stabilize the cornea similarly to treatment with CXL. One study evaluated topographic corneal changes in three individual cases of patients ingesting 400mg to 800mg of riboflavin supplements daily. Researchers observed corneal flattening and improved visual acuity in each case—similar outcomes to CXL."